Germany has approved
the first human trials of a possible COVID-19 vaccine.
The trial vaccine is
said to be the fourth of its kind in the world to get approval for clinical
testing.
The German Federal
Institute for Vaccines said Biontech, a Mainz-based company, made the potential
vaccine for COVID-19.
The vaccine, named
BNT162, was developed alongside Pfizer, another pharmaceutical company.
According to the
institute, 200 healthy people between the ages of 18 and 55 will be
administered doses of the drug at the initial stage of the trial, while the second
phase will be administered on higher-risk individuals.
The clinical testing
of BNT162 will also be done in the United States.
The World Health
Organisation (WHO) said there are about 20 different potential COVID-19
vaccines currently in development.
The United Kingdom
had announced that there would be clinical trials of a possible COVID-19
vaccine on patients from Thursday.
The vaccine, called
ChAdOx1 nCoV-19, is being developed by scientists at the University of Oxford.
According to
Worldometers, the number of confirmed cases of COVID-19 has exceeded 2.5
million globally, with 178,558 deaths. But 701,838 patients have recovered from
the disease.
Click to signup for FREE news updates, latest information and hottest gists everyday
Advertise on NigerianEye.com to reach thousands of our daily users
No comments
Post a Comment
Kindly drop a comment below.
(Comments are moderated. Clean comments will be approved immediately)
Advert Enquires - Reach out to us at NigerianEye@gmail.com